Why is the baroreflex a relevant target for both resistant hypertension and heart failure?

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Baroreflex activation therapy: its role in the management of heart failure and resistant hypertension CHF - Non pharmacological treatment ESC Premium Access ESC Congress 2017

About the speaker

Photo

Institut de Chirurgie Cardiaque et de Cardiologie Interventionnelle, Luxembourg (Luxembourg)

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

ESC 365 is supported by